Arts Way director gets 1,000-share stock grant

Arts Way Manufacturing director Thomas E. Buffamante acquired 1,000 shares of common stock through a fully vested restricted stock grant under the director compensation plan.

Rhea-AI Filing Summary

Arts Way Manufacturing director Thomas E. Buffamante acquired 1,000 shares of common stock through a fully vested restricted stock grant under the director compensation plan. The grant was recorded at $0.00 per share and raised his directly held stake to 59,000 shares.

Insider Trade Summary

Grant/Award: 1,000 shares

Grant/Award 1 txn

Insider Buffamante Thomas E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 59,000 shares (Direct)

Footnotes (1)

1. F1. Represents fully-vested restricted stock granted pursuant to the director compensation plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ARTW director Thomas E. Buffamante report?

Thomas E. Buffamante reported acquiring 1,000 shares of Arts Way Manufacturing common stock. The acquisition came as a fully vested restricted stock grant issued under the company’s director compensation plan, rather than an open-market purchase, and increased his directly owned holdings to 59,000 shares.

How many Arts Way (ARTW) shares does Buffamante own after this Form 4/A?

After the reported transaction, Thomas E. Buffamante directly owns 59,000 shares of Arts Way Manufacturing common stock. This reflects the addition of 1,000 fully vested restricted shares granted under the director compensation plan, as disclosed in the amended Form 4 filing for the director.

Was the ARTW director stock grant an open-market purchase?

No, the 1,000-share increase was not an open-market purchase. It was a fully vested restricted stock grant awarded under Arts Way’s director compensation plan, reported with a price of $0.00 per share, which is typical for equity compensation awards rather than cash purchases.

What does the Form 4/A say about the nature of ARTW shares granted?

The filing states the 1,000 shares represent fully vested restricted stock granted under the director compensation plan. This means the shares were issued as compensation, are no longer subject to vesting conditions, and immediately count toward Thomas E. Buffamante’s directly owned Arts Way common stock holdings.

Is the ARTW Form 4/A transaction categorized as an acquisition or a sale?

The Form 4/A categorizes the transaction as an acquisition. It uses transaction code “A” for a grant, award, or other acquisition, indicating Thomas E. Buffamante received 1,000 fully vested restricted shares of Arts Way common stock rather than disposing of or selling any existing holdings.

How was the price per share reported for the ARTW director grant?

The price per share for the 1,000-share restricted stock grant was reported as $0.00. This reflects that the shares were issued as compensation under the director compensation plan, so Thomas E. Buffamante did not pay cash consideration to acquire these Arts Way common stock shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 09:02 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buffamante Thomas E

(Last) (First) (Middle)

5556 HIGHWAY 9

(Street)

ARMSTRONG IA 50514

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTS WAY MANUFACTURING CO INC [ ARTW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
12/15/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/30/2025		A		1,000(1)	A	$0	59,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents fully-vested restricted stock granted pursuant to the director compensation plan.

Remarks:

Amending to update total number of shares beneficially owned.

	/s/ Michael W. Woods as Attorney-in-Fact for Thomas E. Buffamante	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.